Principal component analysis, a useful tool to study cyclin-dependent kinase-inhibitor’s effect on cerebral ischaemia
Evans Blue
Extravasation
DOI:
10.1093/braincomms/fcaa136
Publication Date:
2020-08-31T18:24:51Z
AUTHORS (7)
ABSTRACT
Abstract Stroke is a leading cause of acute death related in part to brain oedema, blood–brain barrier disruption and glial inflammation. A cyclin-dependant kinase inhibitor, (S)-roscovitine, was administered 90 min after onset on model rat focal cerebral ischaemia. Brain swelling Evans Blue tissue extravasation were quantified injection. Combined fluorescence immunofluorescence endothelial cells (RECA1), microglia (isolectin-IB4) astrocytes (glial fibrillary acidic protein) analysed. Using Student’s t-test or Mann–Whitney test, (S)-roscovitine improved recovery by more than 50% compared vehicle (Mann–Whitney, P < 0.001), decreased significantly (t-test, = 0.0128) mostly the rostral brain. Main analysis therefore performed cut for maximize biological observations (cut B). group (60%, t-test, 0.049) further supported spectrophotometer 0.0002) macroscopic photonic 0.07). An increase RECA-1 intensity observed ischaemic hemisphere non-ischaemic hemisphere. Further study showed, that treated vehicle, showed decrease of: (i) about 20% globally, mainly located cortex (−28.5%, 0.03); (ii) Microglia’s number 55% 0.006) modulated reactive through trend toward less (15%, 0.05) astrogliosis (21%, 0.076). To decipher complex relationship these components, we analysed six quantitative variables our principal component from studies same animals. Principal differentiated non-treated animals dimension 1 with negative values animals, positive Interestingly, stroke presented correlation this dimension, while all other correlation. Dimensions 2 allowed identification two groups co-varying variables: cells, both dimensions, astrocyte number, 2. This partition suggests different mechanisms. Correlation matrix concordant results. Because its pleiotropic action elements NeuroVascular Unit response, may represent an effective treatment against oedema stroke.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (64)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....